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ABSTRACT 
OPTICAL CRYOIMAGING OF CELULAR REDOX  
IN KIDNEYS FROM DIABETIC MICE  
 
by 
 
Sepideh Maleki 
 
 
The University of Wisconsin-Milwaukee, 2012 
Under the Supervision of Professor Mahsa Ranji 
 
 
 Diabetic Nephropathy (DN) is the major single cause of end stage renal diseases 
(ESRD) in the United States. Diabetes is the third leading fatal disorder after cancer and 
heart disease [1]. It is affecting 8.3% of the residents of the United States, with a total 
healthcare cost of $174 billion/yr by 2010 [2].  
There currently exists a need for a sensitive and specific diagnosis for temporal 
detection of oxidative stress (OS) in cellular metabolic levels, which plays an early role 
in the development of DN. The objective of this research is to use a fluorescence optical 
imaging technique in order to delineate temporal and spatial distribution of OS and to 
evaluate mitochondrial redox state in rodents kidney tissue during diabetes progression.  
 In this research, I investigated whether changes in the metabolic state can be used 
as a quantitative marker of OS progression in kidneys. Through the monitoring of 
autofluorescent mitochondrial metabolic coenzymes (NADH, FAD), the redox state of 
mitochondria can be probed in many intact organs. I have applied a device called 
cryoimager to measure the fluorescence intensity of these fluorophores simultaneously in 
3-D. The ratio of these fluorophores, referred to as the NADH redox ratio (RR), can be 
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used as a quantitative metabolic marker of tissue. I examined redox states of kidneys 
from diabetic mice, Akita/+, Akita/+; TSP1-/- (Akita mice lacking thrombospondin-1, 
TSP1) with increasing duration of diabetes, and kidneys from bcl-2-deficient mice. 
  We detected OS shortly after the onset of diabetes by NADH RR, which increased 
during progression of diabetes. RR indicates a more reduced biochemical state in kidneys 
from diabetic mice compared with kidneys from wilde type (control) mice. Thus, cryo 
fluorescence redox imaging showed a quantitative marker of OS progression in kidneys 
from diabetic mice and demonstrated that alterations in the oxidative state of kidneys 
occur at different stages of diabetes. 
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1. Introduction 
Spectroscopic techniques examine different types of light-tissue interactions and 
provide biochemical and morphological information at the molecular, cell, and tissue 
levels in intact organs [3]. In the past several decades, fluorescence spectroscopy has had 
a significant effect on many different fields of research. One field that has seen such 
advancement is biomedical diagnostics. Within this field, fluorescence imaging has been 
applied to the analysis of many different types of samples, ranging from individual 
biochemical species (e.g., NADH, tryptophan) in intact organs to organs of living people. 
These studies have given rise to new methods for the early diagnosis of various medical 
conditions, including diabetes, cancer, lung diseases, and many others. Fluorescence 
analysis, which is capable of producing quantitative measures related to the tissue health, 
is generally classified based upon whether or not the fluorescent species are an 
endogenous (naturally occurring) or exogenous (externally administrated) fluorophores 
[4]. Some of the most intense endogenous fluorophores involved in human and animals 
are the cellular metabolic pathways, which are autofluorescent species, and are the focus 
of this research. Two endogenous fluorophores involved in cellular metabolic pathways 
are Nicotinamide Adenine Dinucleotide (NADH) [5], and the Flavin Adenine 
Dinucleotide (FAD) [6]. 
 Endogenous fluorophores can be structural or metabolic, that can be used for 
disease diagnosis (e.g., diabetes) without requiring exogenous fluorescence tags. Since 
cells at different disease stages possess different metabolism states, there are distinct 
differences in their fluorescent emission spectra. These differences in fluorescence 
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emission depend on at least one of the following parameters: fluorophore concentration 
or spatial distribution throughout the tissue, local microenvironment surrounding the 
fluorophores, and the particular tissue architecture [3]. 
 We monitor metabolic state in diseases of clinically important disorders such as 
diabetic nephropathy, and diabetic retinopathy. The future goal of our research is to 
translate optical fluorescent imaging to clinical avenues, and use this method for 
spatiotemporal diagnosis. 
1.1. My Contributions 
 I have studied cellular metabolic activities of the onset and progression of 
diabetes in rodent models using optical imaging technique. Oxidative stress (OS) happens 
during diabetes due to cellular dysfunction and is detectable after 4 weeks of age. I have 
improved an instrument called cryoimager to quantify the severity of diabetes (and OS) 
in mouse kidneys at different stages. This imaging device specifically measures the 
relative oxidation of two intrinsic fluorophores, in the cell. The ratio of these two 
fluorophores, the redox ratio (RR), acts as a quantitative marker of the metabolic state of 
the tissue. I evaluated the NADH RR by measuring the intrinsic fluorescence properties 
of these fluorophores. Next, I quantitatively showed the progression of OS through RR 
on three different diabetic mouse models. Since the fluorescence of both fluorophores is 
entirely dependent on its oxidation, a comparison between the fluorescence levels of each 
fluorophore yields to a sensitive measure of mitochondrial metabolic state.  
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 As mentioned earlier, I have contributed in improving the design of our 
cryoimager system. A limitation of this device was that for some small-sized samples 
such as mouse eye, there existed a need for higher resolution images as well as stronger 
signals. In order to address this limitation, I have improved the detection section of the 
device, which enables the cryoimager to record higher resolution images. I specifically 
used a sensitive CCD camera for more accurate quantification, decreased the working 
distance between the tissue and lens to obtain a stronger signal, used a high-resolution 
lens with less distortion, and employed a smaller filter wheel between the lens and 
camera for higher magnification. 
1.2. Biological Background 
1.2.1. Cell Structure and the Mitochondrion 
 The basic structural and functional unit of all known living organisms is the cell. 
It is the smallest unit of life that is classified as a living thing, and is often called the 
building block of life [7]. In order to function properly and stay alive, the cells must 
maintain homeostasis. Homeostasis is a state in which everything within the cell is in 
equilibrium and functioning properly [8]. The state of homeostasis keeps the cell constant 
with what it needs to function. This means that in homeostasis, the waste is being 
transported away from the cell while it receives the nutrients it needs to continue to 
function. When cells are in homeostasis, they work to help the organism function 
properly. It is important for cells maintain homeostasis of the organism to remain healthy 
and because of that one of the most important factors in any biological system is cellular 
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and sub-cellular homeostasis [9]. Figure. 1.1 shows a diagram of the typical eukaryotic 
cell [10].   
 
Figure 1.1. Cell Structure. Diagram of the cell including organelle [10]. 
 
 The irregularities in the cell function are due to injuries and diseases within the 
organelles and tissue [11]. Detecting these injuries in their early stages could help in 
prognosis and reducing the therapies cost.  
  A cell consists of many cellular organelles, which are responsible for organism to 
remain healthy and alive, but the one responsible for energy production is 
the mitochondrion. Mitochondria are often referred to as the power plants of the cell 
since energy production takes place in mitochondria [12, 13].  
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  A form of cellular respiration that requires oxygen in order to generate energy is 
termed aerobic respiration. In this process, coenzymes present in the mitochondria is 
oxidized and the resultant energy is ATP usable by cells [9, 14]. Therefore, the amount of 
energy that can be supplied to the cell is highly dependent on the amount of oxygen 
present in the mitochondria. The majority of energy in the cell is produced through 
electron transport chains, which are the cellular mechanisms used for extracting energy 
from redox reactions such as respiration [15]. A diagram of mitochondrial electron 
transport chain is shown in Figure. 1.2 [16].  
 
 
Figure 1.2. Electron Transport Chain. Simplified block diagram of the electron transport chain [16]. 
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 The electron transport chain comprises an enzymatic series of electron donors and 
acceptors. Each electron donor passes electrons to a more electronegative acceptor, which 
in turn donates these electrons to another acceptor. At the mitochondrial inner membrane, 
two proteins, NADH (Nicotinamide Adenine Dinucleotide) and FADH2 (Flavin Adenine 
Dinucleotide), are oxidized through a series of protein complexes, resulting in a release 
of protons, which are pumped into the intermembrane space using a portion of the energy 
released, thus creating a proton gradient. Finally, by using the energy of the hydrogen 
oxidation, electric potential in conjunction with adenosine diphosphate (ADP) and 
inorganic phosphate results in generating adenosine triphosphate (ATP), the cell's basic 
unit of energy. The entire process is called oxidative phosphorylation, since ADP is 
phosphorylated to ATP using the energy of hydrogen oxidation in many steps [7, 17-19]. 
My main interest is in detecting the intrinsic fluorophore NADH and FAD in the chain. 
1.2.2. Mitochondrial Oxidative Stress 
 In the electron transport chain reactions, a small percentage of electrons do not 
complete the whole series and instead directly leak to oxygen, resulting in the formation 
of the free-radicals, highly reactive molecules that contributes to oxidative stress and has 
been implicated in a number of diseases and aging. Oxidative stress (OS) is known as 
excess or shortage of oxygen available to the cells and is caused by an imbalance 
between the production of reactive oxygen and a biological system's ability to readily 
detoxify the reactive intermediates or easily repair the resulting damage. An excessive 
amount of reactive oxygen species can result in the production of peroxides and free 
radicals, which are capable of causing damage to all parts of a cell. Therefore, the amount 
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of oxygen present in and around the cell is an important factor in regulating the 
mitochondrial production and the rate of cell death [20-22]. 
  The energy produced by the mitochondria can be found to be strongly dependent 
on the amount of oxygen available and it has been shown that a vicious circle of OS and 
damage to cellular structures can lead to either cell death by apoptosis or to a cellular 
energetic decline and ageing. Figure 1.3 shows the mitochondrial dysfunction, and 
eventual cell death due to increasing oxidative stress [23]. 
 .  
 
Figure 1.3. Impact of Oxidative Stress. Mitochondrial dysfunction, and eventual cell death due to 
increasing oxidative stress (left to right) [23]. 
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 A variety of diseases cause an improper function of the mitochondria by 
disrupting the balance of oxygen flow into and around cells, which results in an increased 
rate of cell death, via apoptosis or necrosis [24]. In many cases, the amount of oxygen 
available to a cell can accurately represent the health of the cell and be used as a tool for 
diagnosis. This is especially true in cases related to mitochondrial dysfunction or diseases 
related to oxidative stress, such as diabetes. In these cases, the oxidation state (redox 
state) of the tissue serves as a sensitive and reliable measure for evaluation of cell 
behavior. My goal has been on the detection of redox state as a measure of oxidative 
stress damage in the tissue. 
1.3. Fluorescence  
1.3.1. Physical Principles of Fluorescence 
  By definition, fluorescence is the emission of photons from a substance that has 
absorbed photons. In most cases the emitted light has a longer wavelength, and therefore 
lower energy, than the absorbed photons [5]. Fluorescence occurs when an orbital 
electron of a molecule, atom, or nanostructure relaxes to its ground state by emitting 
a photon of light after being excited to a higher quantum state by some type of energy 
such as bright light source or extreme heat. Since the amount of heat required to excite 
the molecules is typically large, a light source is commonly used for this excitation. A 
molecule at the excited energy state (S1) state can relax by various pathways such as non-
radiative relaxation in which the excitation energy is dissipated as heat (lattice vibration) 
to the solvent. Another scenario is that, a relatively small portion of the energy is lost to 
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lattice vibrations prior to the release of extra energy and relaxation to the ground state. 
There is a probability, termed the fluorescence quantum yield, which is the indicator of 
the efficiency of the fluorescence process. It is defined as the ratio of the number of 
photons emitted to the number of photons absorbed. The maximum fluorescence quantum 
yield is 1.0 (100%), which corresponds to every photon absorbed resulting in a photon 
emitted. If the photon emission occurs, a photoelectric device can quantify the amount of 
releasing energy. The fluorescence process can be seen in Figure 1.4 [25]. 
 
Figure 1.4. Jablonski Diagram of Fluorescence. Fluorescence as a result of molecule excitation. Green 
lines indicate excitation, yellow lines relaxation, and red lines emission of fluorescence [25]. 
 
 
  
 For exciting many molecules, and specially the molecules that are intrinsically 
fluorescent corresponding to the allowed energy levels of the molecule, there is a narrow 
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range of light energies. Since the photon energy is in an inverse relation to its wavelength 
or directly proportional to the frequency of the light, only one specific range of 
wavelengths can be used to excite a molecule. The wavelength, or color, of the emitted 
fluorescence light has a narrow range since it has energy equal to the energy released 
when the molecular transitions back to its ground state. 
 
 
Figure 1.5. Stokes Shift. Example excitation and emission spectra of a fluorophore. The difference 
between absorption and emission maxima is known as the Stokes Shift [26]. 
 
   
  
 
 When a system absorbs a photon, it gains energy and enters an excited state. One 
way for the system to relax is to emit a photon, thus losing its energy. When the emitted 
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photon has less energy than the absorbed photon, this energy difference is the Stokes shift 
[27] as seen in Fig. 1.5 [26]. 
 To detect the emitted fluorescence light in this phenomenon, the excitation and 
emission light must be separated by using optical filters or dichroic mirrors. Although the 
narrow range of both the excitation and emission light would seem to be a limiting factor 
in the usefulness of fluorescence due to its necessitation of concentrating power into a 
narrower range, this actually benefits the fluorescence method in that multiple molecule 
can be monitored sequentially, provided that their fluorescence spectra are not completely 
overlapping. 
1.3.2. Intrinsic Mitochondrial Fluorophores 
 Fluorophores are small molecules that can be part of a molecule (intrinsic) or 
added to a molecule (extrinsic). Intrinsic fluorophores are those that occur naturally in 
most tissues and they can be used as natural indicators to study the structure, the 
dynamics, and the metabolism of living cells. These intrinsic fluorophores include 
tryptophan, collagen, NADH, flavins, and porphyrins. Two of these fluorophores, NADH 
(Nicotinamide Adenine Dinucleotide), and Flavoprotein Adenine Dinocleotide (FADH2, 
one of the flavins), are essential in the metabolic pathway of the mitochondria and they 
are located in the protein complexes one and two of the electron transport chain. These 
fluorophores are used to determine the oxidation state of the mitochondria [15]. In 
addition, these coenzymes are autofluorescent, with the spectra shown in Figure 1.6 [28, 
29], in some specific biochemical states [30]. 
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 NADH, and FAD (the oxidized form of FADH2) are the primary electron carriers 
in oxidative phosphorylation, they are autofluorescent and can be monitored without 
exogenous labels by optical techniques. These coenzymes are beneficial in that NADH is 
primarily fluorescent in its reduced biochemical state, whereas FAD is the only 
fluorescent in its oxidized form. Therefore, by imaging these two coenzymes, we can 
probe the oxidative state of the metabolism in tissue. The fluorescent signals of these 
intrinsic fluorophores have been used as indicators of tissue metabolism in injuries due to 
hypoxia [31], ischemia, and cell death [32-34]. Additionally, the normalized ratio of these 
fluorophores, (NADH/FAD), called the NADH redox ratio (RR), acts as a novel marker 
of the mitochondrial redox and metabolic state of tissue ex vivo and in vivo [34]. 
Although this ratio is not a direct measure of the concentrations of these fluorophores, the 
fluorescence intensity measured is a relative measure of their concentrations. This ratio is 
beneficial, as it is a quantitative marker of tissue metabolism independent of the number 
of mitochondria. 
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Figure 1.6. NADH and FAD Fluorescence Spectra. Excitation and emission spectra of NADH (left) and 
FAD (right) [28, 29]. 
 
  By filtering a white light such as mercury-arc light at related excitation 
wavelengths, NADH and FAD can be excited. NADH has a maximum in its excitation 
spectrum at 340 nm (ultraviolet region of the electromagnetic spectrum) and an emission 
maximum at 460 nm (blue in color), and FAD has its excitation maximum at 448 nm 
(blue in color) and a maximum in the emission spectrum at 520 nm (green in color). 
There is an overlap between the NADH emission and FAD excitation, which requires the 
sequential excitation and detection of the two fluorophores. The selective detection of 
fluorescence between the two fluorophores is possible due to the fact that the excitation 
spectra don't overlap each other, and the emission spectra don't overlap either. Hence, the 
fluorescence signal of each of these fluorophores will give us a measure of the health of 
cells within an organ. 
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1.3.3. Interfering Factors 
 The filter sets used in the experiments allow for excitation of other endogenous 
fluorophores, such as collagen, elastin, and NAD(P)H in the NADH channel, and flavin 
mononucleotide in the FAD channel. Since the collagen and elastin fluorescence signals 
are constant regardless of oxidation, thus, they don't impact the change in the 
fluorescence signal and resultant change in the signal is due to metabolic oxidation. 
Flavin mononucleotide is also involved in the metabolism, and its fluorescence behaves 
in the same manner as FAD. 
 NADPH, which is an indicator of tissue oxygenation fluoresces with the same 
characteristics as NADH, however, detection of this enzyme is undesirable since NADPH 
is not related to the metabolism. Fortunately, the signal intensity of NADPH has been 
shown to be much less than that of NADH [34-37], and so can be considered negligible. 
Chance et al. demonstrated that the fluorescence signal originates mostly from NADH in 
the mitochondria and the contribution of NADPH is very small [38]. Other groups 
showed that the concentration of NADH is about 5 times greater  than NADPH, the 
NADH quantum yield is 1.25 to 2.5 times greater than NADPH, and that metabolic 
diseases only affect NADH [35-37]. For these reasons, it is obvious that the changes in 
the redox ratio measured are due to changes in the mitochondrial redox ratio, and are not 
impacted by the other endogenous fluorophores present in the tissue. 
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1.4. Imaging Background 
1.4.1. Optical Imaging 
 Optical imaging techniques for the assessment of tissue anatomy, physiology, 
metabolic, and molecular function have emerged as an essential tool for both the basic 
researcher and clinical practitioner. One main concern of clinical practitioners is that too 
much harmful radiation is used to detect diseased tissue. One main advantage of optical 
imaging techniques arises from the fact that endogenous and exogenous fluorescent dyes 
can be detected at low concentrations, without harmless radiation and can be applied 
repeatedly to the patient. Furthermore, the remarkable progress in the development of 
optical instrumentation in the last two decades has decisively contributed to the growing 
applicability of optical imaging tools , which have the advantage of being less harmful, 
inexpensive and sometime with a reasonable sensitivity and specificity [3]. 
 The term optical imaging encompasses a large variety of different disciplines. In 
our fluorescence imaging method, light in the ultraviolet (UV), and the blue spectral 
region is used to obtain information on the biochemical characteristics of tissue. 
Generally, the interaction of photons with tissue is based on absorption of light, scattering 
of light, and emission of fluorescent. These three parameters can be used separately to 
characterize tissue optical properties. My focus is the third interaction, the fluorescence. 
 A fundamental observation for optical diagnostic procedure relates to the fact that 
the penetration depth of light  in living tissue strongly depends on the wavelength used 
because the amount of absorption and scattering events in tissue is a function of 
wavelength [39-41]. 
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 For wavelengths below approximately 600 nm, the penetration of light into the 
tissue is limited to a depth of hundreds of micrometers up to a few millimeters due to 
strong absorption of the photons, so that only superficial assessment of tissues in this 
spectral region is possible. The absorption of light in tissue originates from oxy- and 
deoxyhemoglobin and several tissue components such as porphyrins, melanin, NADH 
and flavins, collagen, elastin, and lipopigments. Fluorescence of these intrinsic 
fluorescence markers (autofluorescence) has been studied as a source of specific spectral 
information on tissue structure and pathophysiological states [4, 42] and was thoroughly 
exploited to identify diseased tissue areas, e.g., in endoscopy [43, 44] or cardiovascular 
diagnosis [45]. 
 In the past few years, remarkable optical techniques for the imaging and detection 
of diseases have emerged. Imaging modalities in the optical regime have the advantage of 
being sensitive, accessible, relatively low-cost, and rapid. The strength of optical imaging 
technique is that it allows for highly sensitive detection of molecular signals. In that 
respect, existence of endogenous or exogenous fluorophores offers various opportunities 
to the acquisition of optical signals. Several parameters, such as the absorption 
coefficient, fluorescence quantum yields, fluorescence decay times, and fluorescence 
quenching/recovery process, are accessible for reporting physiological states, molecular 
conditions, and molecular function.  
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1.4.2. Fluorescence Imaging 
 Fluorescence imaging provides specific information on tissue using intrinsic 
fluorophores or exogenous tagged proteins. Since some of the molecules in the cell have 
intrinsic fluorophores and are able to fluoresce when excited with the appropriate 
wavelength, a growing field of fluorescence spectroscopy and imaging techniques relies 
on autofluorescent fluorophores. In this method, the intrinsic fluorescence of some of the 
fluorophores present in the cell can be used to determine the amount of oxygen existent 
in the cell's environment. Fluorescence-based techniques are widely used in biomedical 
applications as diagnostic/therapeutic tools for early detection of various diseases and to 
probe tissue redox state and energy homeostasis in organs such as the heart [46], brain 
[47], kidney [48, 49], liver [50], skeletal muscles [51], cervix [52], and colon [53]. These 
techniques are widely used in biomedical applications and have been shown to have a 
high sensitivity and specificity for discriminating between diseased and non-diseased 
tissue. In this research, fluorescence imaging was used to evaluate the kidney 
mitochondrial redox state [49, 54]. 
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1.5. Disease Model 
1.5.1. Diabetic Nephropathy 
  Diabetic nephropathy (DN) is a progressive kidney disease caused by diabetes. 
Diabetes is classified into two types, which is: type 1 diabetes also called insulin-
dependent diabetes, and type 2 diabetes, called non-insulin dependent diabetes. In type 1, 
the pancreas cannot produce enough insulin or produce no insulin. With limited levels of 
insulin produced, glucose cannot be delivered into fat, liver cells and muscle for energy, 
which leads to deposition of large quantities of blood glucose in the body. Then, the high 
level of glucose occurs accordingly. In type 2, the cells cannot respond properly to the 
insulin, which shows one condition that the inability of the cells to make full use of 
insulin [55-57]. 
 In the kidneys, there are millions of tiny blood vessels (capillaries) with tinier 
holes in them, which are responsible for filtering the waste products caused by protein 
digestion. As blood flows through the blood vessels, small molecules such as waste 
products squeeze through the holes and these waste products become part of the urine. 
Useful substances, such as protein and red blood cells, are too big to pass through the 
holes in the filter and stay in the blood. High blood sugar from diabetes can destroy these 
blood vessels and make the kidneys filter too much blood. When diabetes damages this 
delicate filtering system, the result is diabetic nephropathy. Severe damage can lead to 
kidney failure or irreversible end stage renal disease (ESRD), requiring dialysis, or a 
kidney transplant [58-60]. 
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1.5.2. Mitochondrial Dysfunction in Diabetes 
 Oxidation-reduction or redox reactions are pivotal to maintaining cell life through 
respiration, metabolism, and energy supply. Oxygen free radicals, known as super oxide 
(O2), leak from the mitochondria and react with the other molecules to create reactive 
oxygen species (ROS). The inability of a cell's antioxidant defense to overcome oxidative 
injury over time will eventually lead to cell death [60, 61].  
 Hyperglycemia or high blood sugar is a condition in which an excessive amount 
of glucose circulates in the blood plasma. Excess generation of highly reactive  free 
radicals, largely due to hyperglycemia, causes oxidative stress, which further exacerbates 
the development and progression of diabetes and its complications [62-64].  
 Diabetes can trigger excess generation of ROS and plays an important role in 
increasing OS in various tissues, including the kidney. When OS happens, normal 
cellular respiration is undergoing, resulting in dysregulated mitochondrial free radical 
production and disparity between ROS generation and antioxidant defenses. The 
combination of stress-induced and conventional mitochondrial dysfunction exacerbates 
the progression of disease and its associated complications such as renal vascular and 
proximal tubule dysfunction [65-67], cancer [68], and pulmonary diseases [69]. 
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1.5.3. Mice Models of Diabetes 
B Cell Lymphoma Gene (BCL-2)  
 The bcl-2 gene plays an essential role during kidney development and lack of bcl-
2 (Bcl-2-/- mice) enhances apoptosis affecting kidney development and growth. Bcl-2-/- 
mice have a number of defects, including smaller size, and die at six weeks of age from 
polycystic kidney disease and renal failure. Bcl-2 plays a central role in maintaining 
mitochondrial oxidative homeostasis [71, 72]. In addition, bcl-2 expression is 
significantly decreased during diabetes [73], thus, its absence causes a more oxidized 
state in tissue and, as such, the mitochondria is more oxidized in bcl-2-/- mice as 
compared with their controls. In addition, bcl-2 is an anti-apoptotic protein whose 
expression decreases significantly during diabetes, and thus is of direct interest for this 
study. 
 
Akita Model  
 The Akita mouse, which has a mutation in the insulin 2 gene, is a model for 
diabetes. The male Akita mouse has diabetes, while females develop mild diabetes. Akita 
diabetic mice develop type 1 diabetes as early as 4 weeks of age and show normal 
survival until 6 months of age but then show a dramatic decrease in survival with almost 
no survivors from 12 months of age. Enzymatic and non-enzymatic sources contribute to 
ROS observed in the diabetic kidneys, including advanced glycation, mitochondrial 
respiration chain deficiencies, and NAD(P)H oxidase [55, 74]. We have studied OS in 
this model by our optical imaging tools. 
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Thrombospondin-1 (TSP1) 
 Thrombospondin-1 (TSP1) is a potent endogenous inhibitor of angiogenesis, 
whose production is decreased during diabetes. An angiogenesis inhibitor is a substance 
that inhibits the growth of new blood vessels. Our hypothesis is that decreased production 
of TSP1 promotes the development and progression of diabetic nephropathy resulting in 
vascular dysfunction. To test this hypothesis the Akita/+ TSP1-/- is studied to see if lack 
of TSP1 exacerbates the pathogenesis of diabetic retinopathy. The Akita/+TSP1-/- mouse 
is a novel diabetes model that exhibits severe nephropathies with a relatively short 
duration of diabetes compared with the parental Akita/+ mice. Thus, the mice that carry 
the Akita mutation and lack TSP1 (TSP1-/-) serve as a model for severe diabetic 
nephropathy. Here we propose to determine the impact of the combination of these 
genetic modifications on the mitochondrial redox state associated with the onset and 
progression of diabetes. To verify that TSP1-/- genotype itself does not contribute to a 
more oxidized mitochondria, we compared TSP1-/- mice with Akita/+TSP1-/- mice. This 
provides an advantage to study most of the non-proliferative early retinopathies with a 
shorter duration of diabetes. Akita/+TSP1-/- mice are a novel model of diabetes in which 
non-proliferative diabetic retinopathy can be detected with a shorter duration of diabetes 
[49]. We have studied OS in this model by our optical imaging tools. 
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Chapter 2 
Optical Cryoimaging of  
Diabetic Nephropathy 
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2. Cryoimaging 
2.1. Introduction 
 The cryoimager is an automated image acquisition and analysis system consisting 
of software and hardware designed to acquire fluorescence images of tissue sections. 
Barlow Scientific Inc. first implemented this device for measuring the regional blood 
flow from fluorescent microsphere images [75, 76]. The first implementation of this 
device can be seen in Figure 2.1 in which a motor-driven microtome sequentially sections 
frozen tissue at the desired slice thickness while filtered light from a mercury arc lamp 
excites up to five distinct fluorophores in the exposed surface of the tissue block. At each 
slice, a CCD camera records a fluorescence image of the tissue block in pixel dimensions 
of 10µm × 10µm to later be analyzed for fluorophore distribution. The microtome is 
housed in a freezer unit that maintains the sample at -25°C during sample slicing and 
image acquisition. The resolution in the z direction (thickness of microtome slices) can be 
as small as 5 μm. For this study, depending on the kidney's size, different resolutions in 
the z direction were used. In the second design, the field of view of the device was 
improved to 12mm×9mm from the previous version of 65mm×45mm. Further details of 
each design can be found in the following section.  
 Cryoimaging is advantageous over the other methods since it provides a high 
fluorescence quantum yield of NADH and FAD as compared with room temperature, 3-D 
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spatial distribution of tissue NADH and FAD fluorescence intensities, and it is a 3-D 
fluorescence imaging technique. 
 
Figure 2.1. Cryoimager Design. Early design of cryoimager manufactured by Barlow Scientific inc. [75]. 
2.2. Optical Design 
 A 3-D fluorescence imaging system termed the cryoimager was used to evaluate 
the redox state of the metabolism in intact organs. This device uses the autofluorescence 
of the previously mentioned NADH and FAD co-enzymes within the mitochondria to 
determine the cellular redox state. By measuring the fluorescence intensities of a reduced 
protein, NADH, and an oxidized protein, FAD, one can obtain an effective measure of 
the oxidation state of the mitochondria. The use of a 3-D cryofluorescence redox imaging 
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technique allows for measurement of spatiotemporal 3-D fluorescence images of intrinsic 
and extrinsic fluorophores in intact organs.  
2.2.1. Excitation Path  
 Excitation light is generated from a 200 W mercury-arc lamp (Figure 2.2-1; Part 
Number 6283NS, Newport Instrument, CT, U.S.A) resulting in a broadband, intense 
white light that can be used to excite multiple fluorophores.  
 
Figure 2.2. Cryoimager Excitation. Block diagram of the components which make up the excitation side 
of the cryoimager. 1) Mercury-arc lamp. 2) Cold mirror. 3) Filter wheel. 4) Mirror 
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 The white light from the mercury arc lamp is then coupled into a condenser, 
which homogenizes the light. The light is then incident on a cold mirror (Figure 2.2-2) to 
get rid of the infrared portion. The homogeneous light is then delivered to a filter wheel 
(Figure 2.2-3). The filter wheel is then used to rotate a set of optical bandpass filters to 
select the proper wavelengths for excitation of each fluorophore. These optical bandpass 
filters allow transmission through a specified range of wavelengths, whereas light outside 
the transmitted range is attenuated by approximately 5 orders of magnitude, with a very 
narrow transition regime (< 5 nm). The excitation light was filtered at the excitation 
wavelength of NADH and FAD, The excitation band pass filters used for NADH is 350 
nm (80 nm bandwidth, UV Pass Blacklite, HD Dichroic, Los Angeles, CA) and for FAD 
is 437 nm (20 nm bandwidth, 440QV21, Omega Optical, Brattleboro, VT). After passing 
through the appropriate filter, the excitation light, which is now a narrow range within the 
excitation spectrum of the desired fluorophore, is then reflected by a mirror (Figure 2.2-
4), transmitted through a glass viewport, and reaches the tissue surface.  
2.2.2. Detection path 
 After light is exposed on the tissue surface, the emitted fluorescent light is 
collected via passage through another filter wheel. The emitted light is then coupled into 
a lens and a CCD camera records a fluorescence image of the tissue block in desired pixel 
dimensions to be later analyzed for fluorophore distribution. 
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First Design 
 In the first design, the cryoimager was capable of low resolution images (45mm× 
40 mm) for large-sized samples such as rat lung, pig heart, etc. Figure 2.3 shows a sample 
grid image and a slice of a rat lung sample provided by the cryoimager's initial setting. In 
this design, the steps are nearly the same as what was described earlier, except the 
detection part, which is the difference between the two designs. The lamp and the 
excitation filter wheel are the same in both designs but the camera, lens, emission filters, 
emission filter wheel, and the working distance between the tissue surface and lens were 
changed for different sample imaging. The working distance between the tissue surface 
and the lens was 38.8 cm and, because of that higher distance, a large emission filter 
wheel was used in between the tissue surface and the lens. The specification of the 
emission filters on the filter wheel is as follows: the emission filter for NADH is 460 nm 
(50 nm bandwidth, D460/50M, Chroma, Bellows Falls, VT) and for FAD is 537 nm (50 
nm bandwidth, QMAX EM 510-560, Omega Optical, Brattleboro, VT). The lens used in 
this setting was a Pentax TV zoom lens (D2560997, Pentax Corporation, Japan) and 
images were collected with an Exi Aqua color (QImaging EXi Aqua, Canada) CCD 
camera. The camera features a low dark current, 6.45 micron pixels, and a high quantum 
efficiency.  
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                                           (a)                                                           (b) 
Figure 2.3. Cryoimager's first design low resolution images (45mm× 40 mm). a) Grid b) A sample rat 
lung image 
 
 As described earlier, after light is exposed on the tissue surface, the emitted 
fluorescent light is collected via passage through large emission filter wheel (Figure 2.4-
1). The emitted light is then coupled into pentax lens (Figure 2.4-2) and an aqua camera 
(Figure 2.4-3) records a fluorescence image of the tissue block. 
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Figure 2.4. Cryoimager Detection. Block diagram of the components which make up the detection side of 
the cryoimager's first design. 1) Emission filter wheel. 2) Pentax lens. 3) Aqua Exi camera [77, 78]. 
 
 However, there was a major disadvantage to this implementation; the system 
needed higher resolution and stronger signals for imaging of small-sized samples such as 
the mouse's eyes. We addressed this limitation by improving the detection section of the 
device that led to the second design explained in details in the next section. 
Second Design 
 To improve the problem mentioned in the first design, the detection section of the 
cryoimager was redesigned, resulting in the second iteration, which enabled the 
cryoimager to have higher resolution. Figure 2.5 shows a sample grid image and a slice 
of a mouse eye sample provided by the cryoimager's second design demonstrating a 
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higher resolution obtained. In this implementation, the working distance between the 
tissue surface and the lens was reduced to 9.5 cm to get a stronger signal from the tissue. 
The lens was changed to a canon (EF 28-135mm, f/3.5-5.6 IS) standard zoom lens with 
less distortions, and higher resolution. In this design, since we need a lower distance 
between the tissue and the lens, a smaller filter wheel is used between the lens and 
camera that led to higher magnification. The emission filters for NADH is 445 nm (90 
nm bandwidth, HQ 445/90M, Chroma, Bellows Falls, VT) and for FAD is 520 nm (35 
nm bandwidth,FF01-520/35-25, Semrock, Rochester, NY).  Finally, the camera used in 
this setting is a rolera (QImaging, EM-C2 Rolera, Canada), which is featured with lower 
noise, high speed dynamic range, and more sensitive in terms of signal detection. 
 
 
                                              (a)                                                 (b) 
Figure 2.5. Cryoimager's second design high resolution images (7mm× 8 mm). a) Grid b) A sample 
mouse eye image. 
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 In this setting [79], after light is exposed on the tissue surface, the emitted 
fluorescent light first passes through a high resolution canon lens (Figure 2.6-1). The 
small emission filter wheel (Figure 2.6-2) is positioned right after the lens to band-pass 
filter the light at the desired emission wavelengths. Afterwards, an aqua CCD camera 
(Figure 2.6-3) records a fluorescence image of the tissue surface.   
 
Figure 2.6. Cryoimager Detection. Block diagram of the components which make up the detection side of 
the cryoimager's second design. 1) Canon zoom lens. 2) Small emission filter wheel. 3) Rolera camera [79, 
80]. 
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Current Design 
 The third, and current, design of the device is a compromise between the first and 
the second design to obtain high resolution images while maintaining the field of view 
necessary for samples such as the mouse kidneys presented in this research. Figure 2.7 
shows a sample grid image and a slice of a mouse kidney sample provided by the 
cryoimager's current setting. In the current setting, the combination of the big emission 
filter wheel from the first design, the high-resolution canon lens, and the Rolera camera 
from the second design are used. The working stage inside the device which the sample 
block is mounted on, is moving towards the lens. Thus, the working distance, i.e. the 
distance between the tissue surface and the lens is 24.3 cm, which is between the first and 
second design's distance. In this distance, the signal from the tissue surface is still strong 
and the field of view is large enough to image a whole kidney. This version of the 
cryoimager is suitable for imaging kidney samples since the kidneys are not as large as 
mouse lungs to need low resolution images and not as small as mouse eyes to need high 
resolution imaging.  
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                                               (a)                                            (b) 
Figure 2.7. Cryoimager's current design intermediate resolution images (9mm× 15 mm). a) Grid b) A 
sample mouse kidney image. 
2.2.3. Entire System 
 A schematic summarizing the design of the cryoimager along with a picture of the 
actual system can be seen in Figure 2.8 and Figure 2.9. The light path begins with the 
mercury-arc lamp, where the light is guided to a cold mirror. The other side of the cold 
mirror is connected to an excitation filter wheel, where desired wavelengths of light are 
selected. This light is then delivered through a mirror to the tissue. The emitted 
fluorescent light from the tissue is then incident on the emission filter wheel as mentioned 
in the current design of the detection section. 
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Figure 2.8. Cryoimager Schematic. Block diagram of the components which make up the cryoimager 
[49]. 
 
 
Figure 2.9. Cryoimager. 
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2.3. Hardware Components 
2.3.1. Microtome Blade 
 The cryoimager contains a removable sharp blade that is positioned in the blade 
mount as can be seen in Figure 2.10 (a). The blade mount is then placed in the blade 
holder slot in the cryoimager and is powered by an AC motor (Blador, 1/3 HP AC motor 
VL 3501). The movement of the blade is controlled through a sensor that is located on 
top of the blade holder. Figure 2.10-b shows the sensor and the position of the blade 
inside the cryoimager. 
 
 
                                      (a)                                                              (b) 
Figure 2.10. Microtome blade. a) Blade mount. b) Blade and sensor’s position inside the cryoimager. 
 
2.3.2. Ultra-Low Freezer 
 The cryoimager includes an ultralow freezer, in which the inside temperature is 
controlled by an accurate interchangeable temperature sensor. To begin cooling the 
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sample chamber, the freezer should be plugged in and the control switch should be turned 
on. It takes 2-3 hours to cool down to the imaging temperature (-250c). 
2.3.3. Filter Wheels 
 Two optical filter wheels rotate simultaneously to provide excitation/emission 
required for imaging fluorophores. Each of these filter wheels carries up to five different 
filters for simultaneous fluorophore imaging.  
 The excitation filter wheel is located in front of the mercurey-arclamp. A 
controller and a stepper motor (Oriental Motor Vexta Step Motor PK268-01B) with a 
step of 1.8 degrees moves the excitation filter wheel. This filter wheel could be 
dismounted for changing the filters.  
 The emission filter wheel is located between the glass viewing window and the 
camera. A controller and a stepper motor (Oriental Motor Vexta Step Motor PK268-01B) 
with a step of 1.8 degrees moves the filter wheel.   
2.3.4. Camera 
 The CCD camera is located along with the glass viewing window and the lens. In 
the current design, the camera is mounted on a rail, which allows the forward, backward, 
and side-to-side movement easily. In this study, two different cameras were used, 
QImaging's EXi Aqua and Rolera EM-C2. The Rolera is an EMCCD with high sensitivity 
and gain. 
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2.3.5. Lamp 
 The lamp used in this study is a 200 W mercury-arc lamp and the lamp module is 
located behind the excitation filter wheel. This type of lamp is of particular interest due to 
intense spectral peaks corresponding to the excitation peaks of both fluorophores of 
interest. Specifically, it has a peak at 365 nm that falls at the peak of the NADH 
excitation spectrum and a peak at 436 nm, which is at the peak of the FAD excitation 
spectrum as can be seen in Figure 2.11. After ignition, the lamp must remain lit at least 3 
minutes to allow for warm-up and to reach its highest power. 
 
 
Figure 2.11. Spectral intensity of mercury-arc lamp [81]. 
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2.4. Sample Preparation for Cryoimaging 
 There are several steps before the sample is ready for cryoimaging, including 
tissue preparation, sample freezing, mounting medium preparation, and sample 
embedding. These steps are explained in more detail in the following sections. 
2.4.1. Tissue preparation 
 Ins2Akita heterozygous (Akita/+) male mice were obtained from Jackson 
Laboratories, where the colony is maintained by breeding C57BL/6J inbred females with 
Ins2Akita heterozygous males. Control animals were C57BL/6J male littermates. Only 
male mice were used in the experiments described below. All diabetic mice were left 
untreated. The Institutional Animal Care and Use Committee of the University of 
Wisconsin-Milwaukee approved all procedures. Genomic DNA was prepared from tail 
biopsies and the transgenic Akita/+ mice were identified by PCR screening using the 
following primers: 5′-TGCTGATGCCCTGGCC TGCT-3′ and 5′-TGG 
TCCCACATATGCACATG-3′. The amplified fragments were digested with FNU 4 HI, 
as recommended by Jackson Laboratories.  
 To generate Akita/+TSP1–/– mice, Akita/+ male mice were bred with TSP1–/– 
female mice. The resulting Akita/+TSP1+/– male mice were then bred with TSP1–/– 
female mice. Akita/+TSP1–/– male mice were determined by screening and the colony 
was maintained by breeding the respective male mice with TSP1–/– female mice. The 
litters were screened for Akita/+ and TSP1–/–. 
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2.4.2. Freezing protocol and storage 
 After the organs are experimentally prepared, the samples should be frozen 
through the following protocol. In order to preserve tissues metabolic state, flash freezing 
in liquid Nitrogen (LN2) is used. Before putting the tissue in LN2, first it is placed in the 
isopentane (2-methyl butane). A stainless steel or Pyrex container of isopentane is held in 
a Dewar flask, containing LN2. Isopentane could be chilled in LN2 (-176 C) for a smooth 
freezing. The isopentane will start to become opaque as it nears freezing. The isopentane 
should be chilled near to the end of the experiment when the tissue is ready to be frozen. 
The tissue is immersed in isopentane for 1-2 minutes. Then the tissue is removed from 
isopentane, and placed in LN2. This method has the advantage of very rapid freezing 
without cracking due to sudden temperature change. For fluorescence imaging, we need 
to embed the tissue in specific mounting medium that is not fluorescent in excitation 
wavelengths of interest. Frozen tissues can be stored in a LN2 dewar or an ultralow 
freezer (-80 C) to be imaged later.  
  
2.4.3. Mounting medium preparation 
 The mounting medium is prepared in the Biophotonics lab (UWM), using 
Polyvinyl Alcohol (PVA, Grade 71-30, PVOH7130, Chemical Store Inc.,Clifton, NJ), 
distilled water and carbon black powder (Daniel Smith Dry Pigment, 284030040, Daniel 
Smith Inc., Seattle, WA). To make one liter of the embedding medium, 80 g of PVA is 
added to 920 g of boiling distilled water and stirred to make a homogeneous transparent 
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medium. Then the solution is cooled down and 80 g of carbon black is added and mixed 
thoroughly and refrigerated for 4-5 days before use. 
2.4.4. Sample embedding in black mounting medium 
 The first step to embed a tissue sample is to prepare a chilled sample plate (Figure 
2.12-a) and a teflon container (Figure 2.12-b), which sits on top of the plate (Figure 2.12-
c). Prior to embedding the frozen tissue sample in a teflon container, a layer of black 
mounting medium 0.5 to 1 cm thick was frozen to the bottom of the container as the base. 
 
 
                       (a)                                              (b)                                            (c) 
Figure 2.12. Sample embedding tools. a) Sample plate. b) Teflon container. c) Container on top of the 
plate. 
 
 The tissue sample is prepared by trimming any excess tissue, especially fat tissue 
that will fluoresce under certain filter combinations, and by rinsing off any frost with de-
ionized water. The surface of the frozen mounting medium should be scored to provide 
grip for the fresh layer of the mounting medium and the sample, which is put on the 
surface. The sample is firmly placed on the puddle as can be seen in Figure 2.13(a) and 
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the container is filled with the black mounting medium until the sample is covered. This 
assures complete envelopment of the sample by the mounting medium. While pouring the 
mounting medium, bubbles should be avoided to maintain the image quality. After 
embedding the sample, the container is placed in the ultralow freezer for 8-10 hours 
before imaging. Figure 2.14(b) shows a sample block ready for cryoimaging. 
 
 
                                               (a)                                            (b) 
Figure 2.13. Sample embedding. a) Sample on the mounting medium. b) Sample block ready for 
cryoimaging. 
 
2.4.5. Sample plate mounting in cryoimager 
 After the sample is securely frozen onto the plate, the sample plate is mounted on 
the sample carriage in the cryoimager using four nuts. Movement of the sample carriage 
stage is controlled through the computer using a controller and a stepper motor (Oriental 
Motor Vexta Step Motor PK268-01B) with step size of 1.8 degrees. The stage on which 
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the plate is mounted moves back through the software until it is exactly in front of the 
blade.  
2.5. Imaging Software  
 To control all of the hardware movements, as well as record the images and 
display them while slicing is in progress, a LabVIEW program is written. Once the 
program starts, it checks the presence of the excitation and emission filter wheels, the 
sample setup motor, and the Q Imaging camera. The software controls the imaging 
through three primary panels: main, setup, and acquire. These three are responsible for all 
aspects of the program including showing the cooling status of the camera, changing the 
camera settings, setting up file location, positioning the filter wheel, positioning the 
sample and setting the slice thickness, adding a new filter set to the experimental setup, 
and controlling the automated image acquisition. In the following sections, the imaging 
software operation will be explained in more detail. 
2.5.1. Camera cooling status 
The main panel is the top-level instrument panel for the cryoimager program and 
includes a display of the current camera temperature and a cooling status, which indicates 
whether the camera has reached the regulated temperature lock. A snapshot of the main 
panel can be seen in Figure 2.14. 
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Figure 2.14. Main panel. Showing the cooling status of the camera. 
 
2.5.2. Imaging setup  
The setup panel is the gateway panel to control the majority of the cryoimager subsystem 
configuration. This panel enables the user to change the camera settings, introduce the 
file location, change the position of the filter wheel, move the sample inside the 
cryoimager and determine the slice thickness, and finally add a new filter set to the 
experimental setup. A snapshot of this panel with its subsystems can be seen in Figure 
2.15. 
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Figure 2.15. Setup panel. A snapshot of setup panel and its subpanels. 
 
 
Camera configuration setup 
 The setup camera subpanel modifies the camera configuration for each filter set in 
the experiment. A live display of the sample is also shown to see the result of 
modifications applied to the camera configuration. A snapshot of the setup camera panel 
can be seen in Figure 2.16.  
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Figure 2.16. Setup camera subpanel. Modifying camera configurations. 
 
The camera exposure time is set in intervals of 1 msec and the valid value range is 
from 1 msec to 59 minutes. The normalized camera gain could be set in the range of 
0.804 to 34.7 for the Aqua Exi camera, whereas the electron-multiplying gain can be set 
from 0 to 4095 for the Rolera camera. The excitation and emission filters for each filter 
set can be controlled by entering their appropriate position number. The valid value range 
of both filters is 1 to 5. To control the frequency of imaging on each channel, in terms of 
the number of slices between imaging, the increment parameter can be used. 
 
Image file setup 
 The setup image file subpanel modifies the image file destinations and 
configurations for each filter set in the experiment. New filter sets can be added or the 
existing filter set can be removed. Image file types supported by the software are BMP, 
JPEG, PNG, TIFF, and AIPD, of which PNG is chosen for our experiments, since it 
involves lossless compression. The amount of compression applied to the image files can 
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be defined as well. The valid value range is from 0 to 1000 and a higher value 
corresponds to less compression. In our experiments, the image quality is set to 600. 
Figure 2.17 shows a snapshot of the setup file subpanel. 
 
 
Figure 2.17. Setup image file subpanel. Modifying the image file destinations. 
 
Filter wheel setup 
 The setup filter wheel subpanel calibrates both of the filter wheels by adjusting 
the zero sensor offsets. The excitation zero offset is the offset from the zero sensor 
position to the first filter position of the excitation wheel and it is set to 53 in our 
experiments. The emission zero offset is the offset from the zero sensor position to the 
first filter position of the emission wheel and it is set to 41 in our experiments. Figure 
2.18 shows a snapshot of the filter wheel subpanel. 
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Figure 2.18. Setup filter wheels subpanel. calibrating the filter wheels. 
 
Sample setup for cryoimaging 
 The setup sample subpanel positions the sample block and sets the sampling slice 
width. The travel direction of the sample translator can be set to move away from or 
towards the blade and a display shows the relative distance the sample has traveled in 
mm. The width of a single sample slice can be set between 1.59 µm to 1 cm. Figure 2.19 
shows a snapshot of the setup sample subpanel. 
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Figure 2.19. Setup sample subpanel. Positioning the sample block and setting the slice thickness. 
 
2.5.3. Controlling the image acquisition  
The automated image acquisition panel for the cryoimager experiments enables 
the user to start slicing the sample, and collecting images for each filter set in the 
experiment, as well as pausing or stoping the slicing and imaging after the current scan is 
completed. A snapshot of the image acquisition panel is shown in Figure 2.20. 
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Figure 2.20. Image acquisition panel. Image acquisition control. 
2.6. Sample Images from Cryoimager 
 Aqua camera captures color images with the pixel size of 6.45µm × 6.45 µm and 
total pixel number of 1392 × 1040 in an image. The digital output of this camera is 8 
bits/14bits and the images captured by this camera have high resolution. Rolera camera 
captures images with the pixel size of 8 µm 8 × µm and total pixel number of 1004 × 
1002 in an image. The digital output of this camera is 8 bits/14bits and the images 
captured by this camera have lower resolution compared to Aqua. Figure 2.21 shows a 
sample panel of NADH and FAD typical kidney images captured by Aqua camera. 
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Figure 2.21. NADH and FAD kidney image panel. The top panel shows the NADH and bottom panel 
shows the FAD kidney images from cryoimager. 
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Chapter 3 
Image Processing 
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3. Image Processing 
3.1. Pre-processing in ImageJ 
 Before processing the images in MATLAB for results, the raw images are loaded 
in ImageJ for the examination of possible problems and correction. Based on the 
thickness in the Z axis chosen during imaging, each kidney sample result in 300 to 400 
images in each of the NADH and FAD channels. All the images, each corresponding to a 
different depth, are then merged into a single file to construct NADH and FAD stacks 
using ImageJ. 
3.1.1. Removing Undesired Slices  
 During tissue slicing, if the chosen slice thickness is very thin (around 10 to 15 
µm), sometimes the tissue surface which was just sliced by the blade folds and attaches to 
the top of the sample block and destroys the next image and the next slide needs to be 
discarded. Figure 3.1 shows some sample slices in a stack of images in NADH channel 
which are removed in this step. Both image stacks of NADH and FAD are searched for 
removal of these unwanted slices. The removal of these undesired slices helps in 
producing more accurate results and better image representation.    
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Figure 3.1. NADH stacks of images. Sample undesired slices in an imaging experiment. 
 
3.1.2. Checking for Intensity and Exposure Changes 
 The NADH and FAD image stacks are then checked for any sudden increase or 
decrease in intensity in the middle of an experiment, which could have been caused by 
the user to prevent saturation or improve the contrast. Figure 3.2 shows two consecutive 
slices in an imaging experiment, in which the exposure time was increased by the user to 
increase tissue intensity and as a result the contrast during imaging. While processing, the 
images compensate for the intensity changes using a linear scaling factor with the 
background as they intercept.  
  55 
 
 
 
Figure 3.2. Intensity change in an experiment. Two consecutive NADH images showing an increase in 
the intensity in an experiment  .  
 
 
3.1.3. Checking for Camera Movement 
 In some experiments, the camera has a slight movement during slicing and 
imaging due to the blade's movement. Figure 3.3 shows the first and the 100th slice in an 
experiment, in which the toothpicks embedded on either side of the sample, where the 
camera movement caused a shift of the image during slicing. The camera movement is 
caused by the blade continuously cutting through the sample block, and each cut induces 
a slight vibration in the stage, to which the camera and lens are mounted. This undesired 
movement can be avoided as in the case in later experiments, by tightening the camera 
and lens to the stage, and securing the lens of the camera in place.  
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Figure 3.3. Camera movement. The first and the last slice in an imaging experiment showing the camera 
movement based on the toothpick's position. 
 
3.1.4. 3-D Reconstruction to check  
 To check if all parts of the sample were imaged correctly and completely, a 3-D 
structure is reconstructed from the raw images. If, for any reason, some part of the sample 
is broken or missed, it can be seen in the 3-D structure. Figure 3.4 shows the 3-D 
reconstructions of a whole and halfway cut kidney, which were imaged properly. 
   
 
Figure 3.4. Kidney 3-D reconstruction from raw images. Whole and half way cut kidney. 
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3.1.5. Imaging Calibration 
 A calibration method was designed to compensate for day-to-day variations of 
light intensity and non-uniformity of the illumination pattern. Figure 3.5 shows all the 
calibration images, which are taken at the beginning of each experiment and before 
slicing the tissue. In the first row on the right an image of the grid is shown, which is 
used to set the focus of the camera before imaging and acquiring the resolution of 
imaging. On the right, a sample dark current image is shown. This image is used for 
background subtraction. 
 The second row shows the images of a phantom captured in NADH and FAD (left 
to right) channels in the same field of view. The phantom was placed in the same position 
as tissue and imaged in all channels. These phantom images are used to correct for day-
to-day light intensity variations and other experimental changes. 
  The third row shows the flat-field images in NADH and FAD (left to right) 
channels. The flat-field image is captured from a uniformly fluorescent and flat object. 
Since the fluorescence of the standard is in both the NADH and FAD channels, it also 
accounts for day-to-day light intensity variations as well as possible non-uniform 
distribution of light on the sample. All the images in each channel were then normalized 
by dividing each image to the flat-field image, captured in the same channel. 
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Figure 3.5. Calibration Images. The first row shows the grid and the dark current image (left to right). 
The second row shows the phantom images taken in NADH and FAD channels, respectively. The third row 
shows the flat-field images in NADH and FAD channels from left to right 
3.2. Redox Calculations and Data Representation 
3.2.1. Reading NADH and FAD Images in MATLAB 
 After pre-processing, FAD and NADH autofluorescence images (containing 300-
400 slices per kidney) from each group of kidneys were loaded in MATLAB (The 
MathWorks, Inc., Natick, MA). The images are then pseudo-colored using the jet 
colormap for ease of visualization and background subtraction. Figure 3.6 shows a 
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sample pseudo-colored image from each of the NADH and FAD channels with the jet 
colormap. After background correction and exposure compensation, NADH fluorescence 
images are divided by the corresponding FAD images to calculate the NADH redox for 
each slice of a kidney sample and to construct the redox stack. Final redox presentation is 
then possible through one of the following methods, depending on the organ and desired 
part of the tissue. 
 
 
Figure 3.6. Pseudo colored NADH and FAD images. One representative image in each set is used for 
background correction.  
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3.2.2.  Representation of Data 
One Slice Representation 
 In this method, one representative slice from the whole sample is chosen to 
display the results. Figure 3.7 shows NADH, FAD, and NADH redox images from one 
slice of a wild type (WT) mouse kidney, which shows one cross-section of the tissue.  
 
 
Figure 3.7. One Slice Method. NADH, FAD, and NADH redox images of a WT kidney. 
 
 
Whole Volume Representation 
In this method, the composite images that were created using all slices in NADH, 
FAD, and redox are used. These 3-D composite images are used for representation and 
comparison of the data and calculation of the histograms. Figure 3.8 shows the rendered 
NADH and FAD images and the redox volume calculations of a WT kidney.  
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Figure 3.8. Whole Volume Method. NADH, FAD, and NADH redox volume images of a WT kidney. 
 
Maximum Projection Representation 
 In this method, the maximum intensities along the z axis of the composite images 
(3-D volume in NADH, FAD, and redox ratio) were calculated and used for 
representation and comparison of the data. Figure 3.9 shows the maximum projection of 
NADH, FAD, and NADH redox in a WT kidney.  
 
 
Figure 3.9. Maximum Projection Method. NADH, FAD, and NADH redox maximum projected images 
of a WT kidney. 
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Discussion on Three Representation Methods 
 The aforementioned three methods have their own advantages and disadvantages. 
The drawback of presenting the results using one slice is the sampling error in which the 
result is only dependent on one slice and may not accurately present the whole tissue's 
redox state. However, it has the advantage of emphasizing a specific part of the tissue, 
which is of more interest. In addition, this method is the least computationally intensive 
of the three. 
 The advantage of the whole volume method is that every single voxel of the 
images is used in redox calculations. This is beneficial in some tissues, such as lung and 
liver, which have almost a homogeneous tissue and the majority of the tissue is of our 
interest in redox calculation. However, in other tissues such as kidney, analysis of the 
entire 3-D volume includes a large portion of tissue, which is not the focus of this 
research. 
 The maximum projection method is advantageous in that it may reveal details, 
which are hidden in the other methods. The kidney is an example in which, the tissue 
shows vascular dysfunction and a higher fluorescence intensity caused by OS during the 
course of diabetes. As a result, application of the maximum projection method 
emphasizes the differences in the components, which does not include the majority of the 
tissue.  
 Figure 3.10 shows a bcl-2 kidney panel with all three methods for representation 
of the results. Bcl-2 plays an essential role during kidney development and a lack of bcl-2 
enhances apoptosis affecting kidney development and growth. It is proven for the bcl-2 
deficient (bcl-2 -/-) mice kidneys to have a more oxidized biochemical state and a lower 
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redox ratio as compared to bcl-2 +/+ mice kidneys. Row one and two in Figure 3.10 
shows the max projected images of bcl-2 +/+ and bcl-2-/-. The histogram on the right 
shows the fluorescence intensity distribution of all kidney images in both groups. The 
histogram shows a 56% change in the mean NADH RR in kidneys from the bcl-2 -/- 
group compared to bcl-2 +/+. Row three and four show the pseudo-colored images of one 
specific slice of the kidney tissue and the histograms on the right show the intensity 
distribution of that specific slice. As can be seen from the histograms, the change in the 
mean NADH RR is about 38% between bcl-2 +/+ and bcl-2 -/-, which is less than the 
first method. Row five and six show the whole volume of the kidneys from bcl-2 -/- and 
bcl-2 +/+ groups and their related volume histograms on the right. The histograms show a 
38% change in the mean NADH RR of the whole kidney volume between the two 
groups, which is less than the changes in the maximum projection method. The changes 
are less in this method since the entire 3-D tissue volume is considered in the redox 
calculations. 
 As can be seen from the histograms of all three methods, the percentage change in 
the mean NADH redox is higher in the first method. Thus, the first method is more 
sensitive in terms of expected results. OS plays an early role in the development of 
vascular dysfunction associated with diabetic nephropathy and by using the maximum 
projection method, we can determine where this OS is occurring in the renal vasculature, 
namely the central region in the kidney tissue.   
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Figure 3.10. Bcl-2 Panel for Three Representation Methods. The first two rows show the max 
projection of NADH, FAD, and NADH redox (left to right)  using all the fluorescence images. The second 
two rows show the pseudo-colored images from one kidney slice. The third two rows show the NADH, 
FAD, and NADH redox of whole kidney volume. The histograms for each method, which are located on 
the right side, show the maximum change in the mean NADH RR in the maximum projection method. 
  
3.3. Statistical Analysis 
 Statistical analysis was also carried out for each group of kidneys using a one-tailed 
student's t-test with P < 0.001 as the criterion for statistical significance. 
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Chapter 4 
Fluorescence Imaging Results 
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4. Results 
4.1. Introduction 
Diabetes, a common metabolic disorder, can trigger excess generation of ROS and 
plays an important role in increasing OS in various tissues, including the kidney. The 
increased OS during diabetes exacerbates the progression of disease and its associated 
complications. However, the temporal and spatial aspects of these changes and, more 
specifically, the time of onset of OS during diabetes remain unknown.  
In this research, six categories of mice with different genotypes were studied, as 
follows. First, bcl-2 -/- mice, which are more sensitive to OS and thus are expected to 
have a lower NADH RR, were compared with their bcl-2 +/+ controls to verify the ability 
of the system to detect differences in OS. Next, Akita/+ and their WT controls were 
studied to determine whether a change in OS is correlated with the presence of diabetes. 
Similar to bcl-2 -/-, Akita/+ mice are more susceptible to OS and are thus expected to 
have a lower NADH RR. Finally, Akita/+TSP1-/- mice were compared with their control, 
TSP1 -/-, in order to evaluate the severity of diabetic nephropathy in these mice using the 
mitochondrial oxidative state as a quantitative marker. It should be noted that the name of 
each group indicates the only modification to the mouse, and thus Akita/+, Akita/+ TSP1 
-/- and TSP1 -/- are not bcl-2 deficient. 
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4.2. Bcl-2 
To ensure that cryogenic fluorescence redox imaging can effectively measure 
increased OS in kidney sections, the NADH RR was initially examined in kidney sections 
of wild type (bcl-2 +/+) and bcl-2-deficient (bcl-2 -/-) mice.  
 Bcl-2 plays an essential role during kidney development and lack of bcl-2 enhances 
apoptosis affecting kidney development and growth, and thus is of direct interest for this 
study. Absence of Bcl-2 causes a more oxidized state in tissue and, as such, the 
mitochondria are more oxidized in bcl-2 -/- mice as compared with their controls.  
The cryogenic fluorescence imaging method was used on kidneys from 3 weeks-old 
bcl-2 +/+ and bcl-2 -/- mice. Figure 4.1 shows the max projected images of NADH, FAD, 
and NADH RR in bcl-2 +/+ and bcl-2 -/- mice kidneys. The NADH RR indicates a more 
reduced biochemical state in kidneys from bcl-2 +/+  mice with a mean value of 5.639 
compared with a much smaller mean value of 2.004 in kidneys from bcl-2 -/- mice. Thus, 
kidney sections from bcl-2 -/- mice consistently demonstrated increased OS as expected, 
and are shown in Figure 4.1 with a decreased NADH RR, confirming the usefulness of 
this method for measuring OS.  
  68 
 
 
 
Figure 4.1.  Representative 3 weeks old bcl-2 kidney panel. Representative max projected images of 
NADH, FAD and RR and their histograms in kidneys from 3 weeks old bcl-2 +/+ and bcl-2 -/- mice. 
 
 
 Bcl-2 is a known modulator of mitochondrial OS and its absence is associated with 
an increased OS state. The NADH RR showed a significant decrease in kidneys from bcl-
2-/- mice as compared with their wild-type counterpart. The difference in mean values of 
the histograms in Figure 4.1 suggests that OS shifts the metabolic levels of cells.       
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4.3. Akita/+ Diabetic Mouse Model and its Control WT 
Akita/+ mice develop type 1 diabetes as early as 4 weeks of age. Akita/+ and their 
WT controls in different diabetic stages (different ages) were studied to determine the 
onset and progression of OS during diabetes. Akita/+ mice are more susceptible to OS 
and are thus expected to have a lower NADH RR compared to their WT in the same age. 
Figure 4.2 shows the pseudo-colored representations of the maximum projection NADH, 
FAD and NADH RR images and histograms of the NADH RR for kidneys from 4, 8, 12, 
and 34 weeks-old WT and Akita/+. As can be seen from the max projected images and 
the histogram, the NADH RR does not show a significant difference in Akita/+ kidneys 
compared to its WT for 4 weeks-old kidneys, indicating that this age corresponds to the 
onset of diabetes. As the kidneys age, the histograms and max projected images show a 
significant decrease in the mean NADH RR of kidneys from 8, 12, and 34 weeks-old 
diabetic mice compared with their WT counterparts. The difference in the mean NADH 
RR becomes more significant in Akita/+ compared to WT by age and due to progression 
of OS as shown by separation of histograms. The histograms shows less than 10% change 
in the mean NADH RR in kidneys from 4 weeks-old diabetic compared to its WT. This 
change increases to 15% for 8 weeks-old kidneys, 28% for 12 weeks-old kidney, and 
33% for 34 weeks-old kidneys. The increasing effect of OS on the kidney mitochondrial 
redox state as evaluated by a decrease in NADH RR can be seen in the histograms of 
Figure 4.2. 
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Figure 4.2. Representative Akita/+ and WT kidney panel. Representative max projected NADH, FAD 
and NADH RR images and their related histograms for kidneys from Akita/+ and mice and their controls in 
different ages. 
To show the effect of age and OS in diabetic mice models, Akita/+ mice of 
different ages were investigated separately. Figure 4.3 shows the max projected images of 
NADH, FAD, and NADH RR as well as the NADH RR histograms of kidneys from 4, 8, 
12, and 34 weeks-old Akita/+ mice. The NADH RR shows a visible decrease in kidneys 
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from 4 weeks-old diabetic mice compared with 8 and 12 weeks-old kidneys, which 
becomes more significant in kidneys from 34 weeks-old diabetic mice. The histograms in 
Figure 4.3 show a 20% change in the mean NADH RR of 4 weeks-old kidney compared 
to 8 weeks-old. This change increase to 44% and 60% for 4 weeks-old kidney compared 
to 12 and 34 weeks-old kidneys. Thus, these results show an increase in kidney OS with a 
longer duration of diabetes. 
 
 
Figure 4.3. Representative Akita/+ kidney panel over age. Representative max projected NADH, FAD 
and NADH RR images and their related histograms for kidneys from 4, 8, 12, and 34week-old Akita/+ 
kidneys. 
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4.4. Akita/+TSP1-/-  a More Severe Diabetic Model 
 The Akita/+TSP1-/- mouse is a novel diabetes model that exhibits severe 
nephropathy with a relatively short duration of diabetes compared with the parental 
Akita/+ mice.  Thus, the mice that carry the Akita mutation and lack TSP1 (TSP1 -/-) 
serve as a model for severe diabetic nephropathy. Here the impact of the combination of 
these genetic modifications has been investigated on the mitochondrial redox state 
associated with the onset and progression of diabetes. To verify that the TSP1-/- genotype 
itself does not contribute to a more oxidized mitochondria, TSP1-/- has been compared 
with Akita/+ TSP1 -/- mice.  
 Figure 4.4 shows the pseudo-colored representations of the maximum projection 
NADH, FAD and NADH RR images and histograms of the NADH RR for kidneys from 
3, 4, and 24 weeks-old Akita/+TSP1-/- and their related controls TSP1-/-. As can be seen 
from the NADH RR histogram for the 3 weeks-old kidneys, Akita/+TSP1-/- and its 
related control are not significantly different in mean NADH RR at this age, indicating 
that the symptoms of diabetes are not yet evident. The histograms show 10% change in 
the mean NADH RR in kidneys from 3 weeks-old AK/+TSP1-/- compared to its control. 
This change increases to 33% for 4 weeks-old kidneys, and 44% for 24 weeks-old 
kidneys. The results presented in the histograms indicate that the mean NADH RR of 
kidney from 4 and 24 weeks-old Akita/+TSP1-/- mice show a more significant decrease 
compared with their control mice, TSP1-/-, which is a direct result of more OS and 
complications due to severe diabetes.  
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Figure 4.4. Representative Akita/+TSP1-/- and TSP1-/- kidney panel. Representative max projected 
NADH, FAD and NADH RR images and their related histograms for kidneys from 3,4, and 24 weeks-old 
Akita/+TSP1-/- and related controls. 
 To show the effect of OS progression with age in severe diabetic mice models, 
Akita/+TSP1-/- mice of different ages were investigated separately. Figure 4.5 shows the 
max projected images of NADH, FAD, and NADH RR as well as the NADH RR 
histograms of kidneys for 3, 4, and 24 weeks-old Akita/+TSP1-/- mice. The NADH RR 
shows a visible decrease in kidneys from 3 weeks-old diabetic mice compared with 4 
weeks-old kidneys, which becomes more significant in comparison to the kidneys from 
24 weeks-old diabetic mice. The histograms in Figure 4.5 show a 40% change in the 
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mean NADH RR of 3 weeks-old kidney compared to 4 weeks-old. This change increased 
to 59% for 4 weeks-old kidney compared to 34 weeks-old kidneys. Thus, these results 
show an increase in kidney OS with a longer duration of diabetes, indicating more severe 
diabetes in these kidney models. 
  
 
Figure 4.5. Representative Akita/+TSP1-/- kidney panel over age. Representative max projected 
NADH, FAD and NADH RR images and their related histograms for kidneys from 3, 4, and 24week-old 
Akita/+TSP1-/- kidneys. 
 Figure 4.6 displays a bar graph plot comparing the mean values of the NADH RR 
histograms of max projected images for kidneys from Akita/+ versus their appropriate 
control male littermates. The results show decreased NADH RR for all Akita/+ mice 
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compared with their non-diabetic control littermates, which becomes more significant in 
12 and 34 weeks-old diabetic mouse kidneys.  
 
Figure 4.6. Bar graph plots for Akita/+ and WT kidneys. Bar graph plot comparing the mean values of 
the NADH RR histograms of max projected images from Akita/+ and their respective controls. The results 
show a significant difference between kidneys from 12 and 34 weeks-old non-diabetic and diabetic Akita/+ 
mice. 
 
 
 The result of the four groups of diabetic mice and their control littermates 
demonstrated different redox images, and the mean values in all four groups showed 
increased OS with the progression of diabetes. Thus, the significant difference in the 
mean NADH RR of kidneys from diabetic mice compared with their appropriate controls 
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indicates that the sensitivity of NADH RR can be used as a marker of renal OS. Since in 
the presence of excessive ROS due to diabetes, the mitochondrial coenzymes NADH and 
FADH2 accumulate in their oxidized forms (NAD and FAD), mitochondrial NADH RR 
showed a decrease as a result of OS. 
 
 Figure 4.7 displays a bar graph plot comparing the mean values of the NADH RR 
histograms of max projected images for kidneys from Akita/+TSP1-/- versus their 
appropriate control littermates. The results show a more decreased NADH RR for all 
Akita/+TSP1-/- mice compared with their control littermates, which becomes more 
significant in 4 and 24 weeks-old diabetic mouse kidneys.  
 
 TSP1 is an endogenous inhibitor of angiogenesis. Therefore, changes in TSP1 
levels during diabetes may contribute to the development and progression of diabetic 
nephropathy. The current study indicates that in the absence of TSP1, the development 
and progression of nephropathy is significantly expedited in a novel diabetic model. The 
results show that lack of TSP1 exacerbates the development and progression of early 
diabetic nephropathy using NADH RR as a quantitative marker of OS. 
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Figure 4.7. Bar graph plots for Akita/+ and WT kidneys. Bar graph plot comparing the mean values of 
the NADH RR histograms of max projected images from Akita/+TSP1-/- and their respective controls. The 
results show a significant difference between kidneys from 4 and 24 weeks. 
 
 Figure 4.8 displays a bar graph comparing the mean values of the NADH RR 
histograms of max projected images for kidneys from Akita/+ versus Akita/+TSP1-/- in 
different ages to show the severity of diabetes in the Akita/+TSP1-/- mice models. The 
results show a larger decrease in NADH RR for all Akita/+TSP1-/- mice compared with 
Akita/+ mice kidneys, which represents the higher OS and more severe diabetes in the 
Akita/+TSP1-/- mice models.  
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Figure 4.8. Bar graphs for Akita/+ and Akita/+TSP1-/- kidneys. Bar graph comparing the mean values 
of the NADH RR histograms of max projected images from Akita/+TSP1-/- and their respective controls. 
The results show a significant difference between kidneys from 4 and 24 weeks. 
 
 In the absence of TSP1, diabetes-related damage to the kidney occurred more 
rapidly, which translated to a further decrease in NADH RR compared with Akita/+ and 
enhanced renal complications. The Akita/+ phenotype (diabetic) is key to affecting 
NADH RR levels. The strong decrease in the mean value of Akita/+TSP1-/- as compared 
with Akita/+, combined with the fact that TSP1-/- does not itself decrease the mean 
value, provides evidence in support of the hypothesis that the lack of TSP1 exacerbates 
the pathogenesis of diabetic nephropathy. The results demonstrate the utility of 
cryoimaging for measuring kidney tissue mitochondrial redox state in different stages of 
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OS associated with the progression of diabetes. The NADH RR reveals differences in 
tissue NADH, FAD, and NADH RR signals between diabetic mice and their control 
littermates.  
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Chapter 5 
Conclusion 
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5. Conclusion 
 
I have studied diabetes cellular dysfunction in rodents kidney tissue by using and 
improving a 3-D optical imaging instrument called the cryoimager. The cryoimager 
allows measurement of mitochondrial redox state of biological tissue for diagnosis of 
nephropathy caused by diabetes. This technique was used to quantify the progression of 
the cellular dysfunction (due to oxidative stress) in three different diabetic models, to 
delineate the temporal distribution of OS during diabetes, and to detect the severity of 
diabetes.  
 The result of three groups of diabetic mice and their control demonstrated relative 
changes in mean value of redox ratio correlated with the severity of the disease. For 
example, in one model of diabetes (e.g. Akita) the mean NADH RR value differences in 
diseased and control animals increased from 8% to 15 % to 28% to 33% from 4 weeks to 
8 weeks to 12 weeks and 34 weeks of the onset of diabetes. This difference in the mean 
NADH RR is due to an increase in OS with the progression of the disease. To account for 
the statistical significance, repeated experiments showed that we reached the significance 
in the 8and 12-weeks rodents with a P<0.001.  
 The future direction of this research is to add the capability of microscopy to our 
cryoimager for cellular-resolution imaging. Cellular imaging allows for the visualization 
and quantification of biological processes of the disease mechanism at the molecular and 
cellular levels. For instance, pericytes that are more specifically located surrounding 
the endothelial cell are affected during diabetes. These cellular images are used to 
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determine the quantity of endothelial cells and pericytes as well as extracting features 
from the structure of the vasculature and vasculature development, which are important 
factors in the development of diabetic retinopathy. 
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7. Appendix 
This section contains the abstracts of the three publications related to this thesis. 
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Abstract: Chronic hyperglycemia during diabetes leads to increased 
production of reactive oxygen species (ROS) and increased oxidative stress 
(OS). Here we investigated whether changes in the metabolic state can be 
used as a marker of OS progression in kidneys. We examined redox states 
of kidneys from diabetic mice, Akita/+ and Akita/+;TSP1–/– mice (Akita mice 
lacking thrombospondin-1, TSP1) with increasing duration of diabetes. OS 
as measured by mitochondrial redox ratio (NADH/FAD) was detectable 
shortly after the onset of diabetes and further increased with the duration of 
diabetes. Thus, cryo fluorescence redox imaging was used as a quantitative 
marker of OS progression in kidneys from diabetic mice and demonstrated 
that alterations in the oxidative state of kidneys occur during the early 
stages of diabetes.
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Optical imaging of tissue mitochondrial redox state
in intact rat lungs in two models of pulmonary
oxidative stress
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Abstract. Ventilation with enhanced fractions of O2 (hyperoxia) is a common and necessary treatment for hypox-
emia in patients with lung failure, but prolonged exposure to hyperoxia causes lung injury. Ischemia-reperfusion
(IR) injury of lung tissue is common in lung transplant or crush injury to the chest. These conditions are associated
with apoptosis and decreased survival of lung tissue. The objective of this work is to use cryoimaging to evaluate the
effect of exposure to hyperoxia and IR injury on lung tissue mitochondrial redox state in rats. The autofluorescent
mitochondrial metabolic coenzymes nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide
(FAD) are electron carriers in ATP generation. These intrinsic fluorophores were imaged for rat lungs using low-
temperature fluorescence imaging (cryoimaging). Perfused lungs from four groups of rats were studied: normoxia
(control), control perfused with an mitochondrial complex IV inhibitor (potassium cyanide, KCN), rats exposed to
hyperoxia (85%O2) for seven days, and from rats subjected to lung IR in vivo 24 hours prior to study. Each lung was
sectioned sequentially in the transverse direction, and the images were used to reconstruct a three-dimensional
(3-D) rendering. In KCN perfused lungs the respiratory chain was more reduced, whereas hyperoxic and IR
lung tissue have a more oxidized respiratory chain than control lung tissue, consistent with previously measured
mitochondrial dysfunction in both hyperoxic and IR lungs. © 2012 Society of Photo-Optical Instrumentation Engineers (SPIE). [DOI: 10
.1117/1.JBO.17.4.046010]
Keywords: optical imaging; nicotinamide adenine dinucleotide; flavin adenine dinucleotide; mitochondrial redox; lung tissue; hyperoxia;
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1 Introduction
Fluorescence imaging techniques provide both anatomical and
functional information of tissue via intrinsic fluorophores or
exogenous tagged proteins.1 These techniques are widely used
to probe tissue redox state and energy homeostasis in organs
suchas theheart,2 brain,3kidney,4–6 liver,7 skeletalmuscle,8 cervix,9
and colon,10 as well as to diagnose diseases, such as breast cancer
tumor localization and oxygenation.11,12 Furthermore, these tech-
niques have been shown to have a high sensitivity and specificity
for discriminating between diseased and nondiseased tissue.13
Tissue metabolic state, which is an indicator of cellular
oxygen consumption, can be extracted from fluorescence
images of intrinsic fluorophores.14,15 The mitochondrial meta-
bolic coenzymes nicotinamide adenine dinucleotide (NADH)
and flavin adenine dinucleotide (FADH2) are the primary elec-
tron carriers in oxidative phosphorylation. NADH and FADH2
oxidation via the electron transport chain results in the translo-
cation of protons from complexes I, III, and IV across the inner
mitochondrial membrane into the mitochondrial inner mem-
brane region. The resulting proton gradient across the inner
mitochondrial membrane, along with adenosine diphosphate
(ADP) availability, controls the rate of mitochondrial adenosine
triphosphate (ATP) synthesis, which accounts for ∼90% of ATP
production in lung tissue. Thus, a change in redox ratio (RR) is
an index of a change in lung tissue bioenergetics.16
NADH and FAD (oxidized form of FADH2) are autofluores-
cent and can be monitored without exogenous labels by noninva-
sive optical techniques.17 The fluorescence signals of these
intrinsic fluorophores have been used as indicators of tissuemeta-
bolism in injuries due to hypoxia, ischemia, and cell death.18
Ranji et al. demonstrated that the ratio of these fluorophores,
termed the mitochondrial redox ratio (RR ¼ NADH∕FAD), is
a marker of the mitochondrial redox and metabolic state of myo-
cardial tissue in intact hearts or in vivo situations.19–22 There is
more than one definition for redox ratio, including the normalized
redox ratio ½NADH∕ðNADHþ FADÞ;18 the definition that is
used in this study (NADH/FAD) is chosen since the FAD signal
in lung tissue, as compared to the NADH signal, is significantly
smaller than in other organ tissues such as the heart. Thus, the
normalized redox ratio would be less sensitive to a change in
mitochondrial redox state than NADH/FAD.
Rapid freeze trapping of organs in liquid nitrogen tem-
peratures preserves the tissue metabolic state. Subsequent
low-temperature fluorescence imaging (cryoimaging) is advan-
tageous since it provides high fluorescence quantum yield of
NADH and FAD as compared with room temperature, and 3-D
spatial distribution of tissue NADH and FAD fluorescence
intensities.21,23,24
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ABSTRACT 
Oxidative stress (OS), which increases during diabetes, exacerbates the development and progression of diabetes 
complications including renal vascular and proximal tubule cell dysfunction. The objective of this study was to 
investigate the changes in the metabolic state of the tissue in diabetic mice kidneys using fluorescence imaging. 
Mitochondrial metabolic coenzymes NADH (Nicotinamide Adenine Dinucleotide), and FADH-2 (Flavin Adenine 
Dinucleotide) are autofluorescent and can be monitored without exogenous labels by optical techniques. The ratio of the 
fluorescence intensity of these fluorophores, (NADH/FAD), called the NADH redox ratio (RR), is a marker of metabolic 
state of a tissue. We examined mitochondrial redox states of kidneys from diabetic mice, Akita/+ and its control wild 
type (WT) for a group of 8- and 12-week-old mice. Average intensity and histogram of maximum projected images of 
FAD, NADH, and NADH RR were calculated for each kidney. Our results indicated a 17% decrease in the mean NADH 
RR of the kidney from 8-week-old mice compared with WT mice and, a 30% decrease in the mean NADH RR of kidney 
from12–week-old mice compared with WT mice. These results indicated an increase in OS in diabetic animals and its 
progression over time. Thus, NADH RR can be used as a hallmark of OS in diabetic kidney allowing temporal 
identification of oxidative state.  
Keywords: Oxidative stress, diabetes, hyperglycemia, Akita diabetic mouse model, NADH redox ratio, fluorescence 
imaging. 
 
1. INTRODUCTION 
Diabetic nephropathy (DN), which is a progressive kidney disease, accounts as a common cause of end stage renal 
disease (ESRD) and a major risk factor for cardiovascular disease 1-5. Chronic hyperglycemia during diabetes can trigger 
excess generation of reactive oxygen species (ROS) and increased oxidative stress (OS). OS in turn may play a key role 
in causing DNA damage, cell death, and protein modifications that result in mitochondrial dysfunction. Diabetes, a 
common metabolic disorder, causes an increase in OS in various tissues such as kidneys from diabetic Akita mice 3, 6-8. 
Akita diabetic mice develop type 1 diabetes as early as 4-weeks of age. ROS observed in the diabetic kidney is due to 
enzymatic and non-enzymatic sources such as advanced glycation, mitochondrial respiration chain deficiencies and 
NAD(P)H oxidase. Redox state of the cell is usually defined as the balance between oxidative species production and 
antioxidant protection of the cells. An imbalance between ROS production and anti-oxidant action of the cells results in 
OS production 1, 5, 9-11. Therefore, the cellular oxygen consumption can be evaluated from tissue metabolic state, and it 
can be extracted from fluorescence images 12, 13. In this study, the OS progression in diabetic Akita mice kidney tissue 
and its control wild type mice was assessed by a quantitative marker using mitochondrial intrinsic signals. Mitochondrial 
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